
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration
Cornelis M. van Tilburg, Lindsay Kilburn, Sébastien Perreault, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Cornelis M. van Tilburg, Lindsay Kilburn, Sébastien Perreault, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Molecular Targeting of the BRAF Proto-Oncogene/Mitogen-Activated Protein Kinase (MAPK) Pathway across Cancers
Khine Shan, Tauseef Ur Rehman, S. G. Ivanov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 624-624
Open Access | Times Cited: 11
Khine Shan, Tauseef Ur Rehman, S. G. Ivanov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 624-624
Open Access | Times Cited: 11
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas
Romain Sigaud, Thomas Albert, Caroline Heß, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Romain Sigaud, Thomas Albert, Caroline Heß, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
The potential of liquid biopsy for detection of the KIAA1549-BRAF fusion in circulating tumor DNA from children with pilocytic astrocytoma
O. I. Krynina, Teresita Díaz de Ståhl, Cecilia Jylhä, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 6
O. I. Krynina, Teresita Díaz de Ståhl, Cecilia Jylhä, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Tovorafenib: First Approval
Sohita Dhillon
Drugs (2024) Vol. 84, Iss. 8, pp. 985-993
Closed Access | Times Cited: 6
Sohita Dhillon
Drugs (2024) Vol. 84, Iss. 8, pp. 985-993
Closed Access | Times Cited: 6
Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation
Ariana Familiar, Anahita Fathi Kazerooni, Arastoo Vossough, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 9, pp. 1557-1571
Closed Access | Times Cited: 5
Ariana Familiar, Anahita Fathi Kazerooni, Arastoo Vossough, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 9, pp. 1557-1571
Closed Access | Times Cited: 5
The tumour microenvironment of pilocytic astrocytoma evolves over time via enrichment for microglia
T. J. Stone, Jessica C. Pickles, Olumide Ogunbiyi, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
T. J. Stone, Jessica C. Pickles, Olumide Ogunbiyi, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer Therapy
Carlien A. M. Bennebroek, J. van Zwol, Maartje C. Montauban van Swijndregt, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 716-716
Open Access
Carlien A. M. Bennebroek, J. van Zwol, Maartje C. Montauban van Swijndregt, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 716-716
Open Access
A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2024
Zinnet Şevval Aksoyalp, Gizem Kaykı-Mutlu, Leszek Wojnowski, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Zinnet Şevval Aksoyalp, Gizem Kaykı-Mutlu, Leszek Wojnowski, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
A paradigm shift in how we treat pediatric low-grade glioma—Targeting the molecular drivers
David S. Ziegler, Rebecca Lehmann, David D. Eisenstat
Neuro-Oncology (2024) Vol. 26, Iss. 4, pp. 593-595
Closed Access | Times Cited: 4
David S. Ziegler, Rebecca Lehmann, David D. Eisenstat
Neuro-Oncology (2024) Vol. 26, Iss. 4, pp. 593-595
Closed Access | Times Cited: 4
Chemotherapy in pediatric low-grade gliomas (PLGG)
Álvaro Lassaletta, Michal Zápotocký, Éric Bouffet
Child s Nervous System (2024) Vol. 40, Iss. 10, pp. 3229-3239
Closed Access | Times Cited: 4
Álvaro Lassaletta, Michal Zápotocký, Éric Bouffet
Child s Nervous System (2024) Vol. 40, Iss. 10, pp. 3229-3239
Closed Access | Times Cited: 4
Striped Hair Colour Change on Tovorafenib in an 18‐Year‐Old Boy With a Brainstem Low‐Grade Glioma
Nicolás André, Caroline Donzé, Gabriel Revon‐Rivière
Pediatric Blood & Cancer (2025)
Closed Access
Nicolás André, Caroline Donzé, Gabriel Revon‐Rivière
Pediatric Blood & Cancer (2025)
Closed Access
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
Stavros Topouzis, Andreas Papapetropoulos, S P H Alexander, et al.
British Journal of Pharmacology (2025)
Open Access
Stavros Topouzis, Andreas Papapetropoulos, S P H Alexander, et al.
British Journal of Pharmacology (2025)
Open Access
Targeted therapy in pediatric central nervous system tumors: a review from the National Pediatric Cancer Foundation
Benjamin I. Siegel, Prabhumallikarjun Patil, Annapoorna Prakash, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Benjamin I. Siegel, Prabhumallikarjun Patil, Annapoorna Prakash, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Targeted therapy for pediatric glioma: RAF(t)ing in the molecular era
Zhi-Peng Shen, Zhongyuan Zhang, Nan Li, et al.
World Journal of Pediatrics (2025)
Closed Access
Zhi-Peng Shen, Zhongyuan Zhang, Nan Li, et al.
World Journal of Pediatrics (2025)
Closed Access
Properties of FDA-approved small molecule protein kinase inhibitors: a 2025 update
Robert Roskoski
Pharmacological Research (2025), pp. 107723-107723
Open Access
Robert Roskoski
Pharmacological Research (2025), pp. 107723-107723
Open Access
Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumors
Florian Selt, Romain Sigaud, Andrey Korshunov, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Florian Selt, Romain Sigaud, Andrey Korshunov, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
European standard clinical practice recommendations for primary pediatric low-grade gliomas
Kleoniki Roka, Katrin Scheinemann, Shivaram Avula, et al.
EJC Paediatric Oncology (2024) Vol. 4, pp. 100169-100169
Open Access | Times Cited: 3
Kleoniki Roka, Katrin Scheinemann, Shivaram Avula, et al.
EJC Paediatric Oncology (2024) Vol. 4, pp. 100169-100169
Open Access | Times Cited: 3
Targeting the RAS/MAPK pathway in children with glioma
Chantel Cacciotti, Uri Tabori, Cynthia Hawkins, et al.
Journal of Neuro-Oncology (2024)
Closed Access | Times Cited: 3
Chantel Cacciotti, Uri Tabori, Cynthia Hawkins, et al.
Journal of Neuro-Oncology (2024)
Closed Access | Times Cited: 3
Future perspective of targeted treatments in pediatric low-grade glioma (pLGG): the evolution of standard-of-care and challenges of a new era
Ashley Plant, Uri Tabori
Child s Nervous System (2024) Vol. 40, Iss. 10, pp. 3291-3299
Closed Access | Times Cited: 2
Ashley Plant, Uri Tabori
Child s Nervous System (2024) Vol. 40, Iss. 10, pp. 3291-3299
Closed Access | Times Cited: 2
A critical review of RAF inhibitors in BRAF-mutated glioma treatment
J. Khoury, Sophie Wehbe, Fouad Attieh, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 7, pp. 343-355
Closed Access | Times Cited: 1
J. Khoury, Sophie Wehbe, Fouad Attieh, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 7, pp. 343-355
Closed Access | Times Cited: 1
Molecular-targeted therapy for childhood low-grade glial and glioneuronal tumors
Benjamin I. Siegel, Elizabeth S. Duke, Lindsay Kilburn, et al.
Child s Nervous System (2024)
Closed Access | Times Cited: 1
Benjamin I. Siegel, Elizabeth S. Duke, Lindsay Kilburn, et al.
Child s Nervous System (2024)
Closed Access | Times Cited: 1
Surgical options of chiasmatic hypothalamic glioma—a relevant part of therapy in an interdisciplinary approach for tumor control
Anna-Gila Karbe, David Gorodezki, Matthias Schulz, et al.
Child s Nervous System (2024) Vol. 40, Iss. 10, pp. 3065-3074
Open Access | Times Cited: 1
Anna-Gila Karbe, David Gorodezki, Matthias Schulz, et al.
Child s Nervous System (2024) Vol. 40, Iss. 10, pp. 3065-3074
Open Access | Times Cited: 1
Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas
Craig Erker, Magimairajan Vanan, Valérie Larouche, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 4022-4029
Open Access | Times Cited: 1
Craig Erker, Magimairajan Vanan, Valérie Larouche, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 4022-4029
Open Access | Times Cited: 1
Role of surgery in the treatment of pediatric low-grade glioma with various degrees of brain stem involvement
Katalin Lőrincz, David Gorodezki, Jens Schittenhelm, et al.
Child s Nervous System (2024) Vol. 40, Iss. 10, pp. 3037-3050
Open Access | Times Cited: 1
Katalin Lőrincz, David Gorodezki, Jens Schittenhelm, et al.
Child s Nervous System (2024) Vol. 40, Iss. 10, pp. 3037-3050
Open Access | Times Cited: 1
Advances in the Treatment of Pediatric Low-Grade Gliomas
İnci Yaman Bajin, Éric Bouffet
Current Neurology and Neuroscience Reports (2024)
Closed Access | Times Cited: 1
İnci Yaman Bajin, Éric Bouffet
Current Neurology and Neuroscience Reports (2024)
Closed Access | Times Cited: 1